Impact of Skeletal Muscle Mass on Long-Term Adverse Cardiovascular Outcomes in Patients With Chronic Kidney Disease

Autor: Hideki Ishii, Kenshi Hirayama, Susumu Suzuki, Yohei Shibata, Ayako Kunimura, Ryota Morimoto, Kazuhiro Kawashima, Yosuke Tatami, Takuya Sumi, Toshijiro Aoki, Yusaku Shimbo, Kazuhiro Harada, Yosuke Negishi, Toyoaki Murohara, Toshiki Kawamiya, Yoshinari Yasuda, Dai Yamamoto
Rok vydání: 2016
Předmět:
Zdroj: The American journal of cardiology. 119(8)
ISSN: 1879-1913
Popis: Sarcopenia, defined as skeletal muscle loss and dysfunction, is attracting considerable attention as a novel risk factor for cardiovascular events. Although the loss of skeletal muscle is common in chronic kidney disease (CKD) patients, the relation between sarcopenia and cardiovascular events in CKD patients is not well defined. Therefore, we aimed to investigate the relation between skeletal muscle mass and major adverse cardiovascular events (MACE) in CKD patients. We enrolled 266 asymptomatic CKD patients (median estimated glomerular filtration rate: 36.7 ml/min/1.73 m 2 ). To evaluate skeletal muscle mass, we used the psoas muscle mass index (PMI) calculated from noncontrast computed tomography. The patients were divided into 2 groups according to the cut-off value of PMI for MACE. There were significant differences in age and body mass index between the low and high PMI groups (median age: 73.5 vs 69.0 years, p = 0.002; median body mass index: 22.6 vs 24.2 kg/m 2 , p
Databáze: OpenAIRE